Medical University of South Carolina
Charleston, South Carolina, 29425, United States
NCT Number: NCT04420793
Depressed patients talk differently when they are depressed compared to when they are well. But it is hard to actually measure what the differences are. The study team will record voice samples from patients with mood disturbances, like depression, over the course of their receiving an electroconvulsive therapy (ECT) series. The study team will try and measure or quantify exactly what has changed in their speech and voice. The study team will choose ECT as it is one of the most effective and rapid treatment for depression. The study team will use a service provided by a company, NeuroLex, who has complex computer programs (artificial intelligence, AI) to analyze the voice samples.
Looking for future studies?
Notify Me18 year–89 year
All sexes
Observational
Charleston, South Carolina, 29425, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3 voice recording tasks and 1 text entry task will be performed.
Time frame: Throughout a course of electroconvulsive therapy (ECT) which may last between 2 and 7 weeks.
crossings per second
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
decibels
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
hertz
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
unitless
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
unitless ratio
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
percentage
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
decibels/log(total word count)
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
W (lexical richness)
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
R (lexical richness)
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
words per minute
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Machine learning approach to evaluate binary outcome: fatigued or awake
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Machine learning approach to evaluate binary outcome: bad or good
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Machine learning approach to evaluate binary outcome: sad or happy
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Machine learning approach to evaluate binary outcome: stressed or not stressed
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Machine learning approach to evaluate binary outcome: male or female
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Machine learning approach to evaluate a categorical outcome of accent region: england, indian, australian, etc.
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
seconds
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Machine learning approach to evaluate estimated decade-age: 10s, 20s, 30s, 40s, 50s, 60s, 70s, 80s, 90s, etc.
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
The voice feature(s) found to have changed most significantly will be compared to Patient Health Questionnaire-9 scores which approach a total score that is less than 8, indicative of reduced depressive symptoms throughout Electroconvulsive Therapy
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Generalized mixed linear model will be used to evaluate which acoustic features change with P value threshold of <0.05
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Generalized mixed linear model will be used to evaluate which linguistic features change with P value threshold of <0.05
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Generalized mixed linear model will be used to evaluate which meta features change with P value threshold of <0.05
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Acoustic voice features will be evaluated using continuous averages using one sample t-tests and we will be testing the difference over time to a null hypothesis of 0 (for no change) in the one sample t-test.
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Linguistic voice features will be evaluated using continuous averages using one sample t-tests and we will be testing the difference over time to a null hypothesis of 0 (for no change) in the one sample t-test.
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Meta-voice features will be evaluated using continuous averages using one sample t-tests and we will be testing the difference over time to a null hypothesis of 0 (for no change) in the one sample t-test.
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
years
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
binary: inpatient or outpatient
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
male, female, unspecified
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
african american, caucasian, hispanic, asian american, etc.
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Diagnosis indicated for receiving ECT
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Total (0-27) on 9 question scale
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Number
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Number
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Number
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Categorical: Sedative, Selective Serotonin Reuptake Inhibitor, etc.
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Binary: yes/no
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Number
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Descriptive, categorical
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Categorical regarding psychiatric diagnoses of family members
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Number
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Number
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Number
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Binary (yes/no)
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
pack-year (total years smoked*average packs per day)
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Binary (yes/no)
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Numerical
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Binary (yes/no)
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Categorical
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
We will evaluate voice features with statistically significant changes against respective participant chart review data using a general linear model with a clustering component for repeated measures which may also be applied to contrast statements evaluating overall change over time (from baseline to end).
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Clinically determined stress level (mood) will be compared to meta-feature extractions of stressed vs. not stressed from voice recordings will be used to calculate an area under the receiver operating curve (AUOC)
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Clinically determined fatigue (motor) will be compared to meta-feature extractions of fatigued vs. awake from voice recordings will be used to calculate an area under the receiver operating curve (AUOC)
Time frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
Clinically determined sentiment (affect and mood) will be compared to meta-feature extractions of happy vs. sad from voice recordings will be used to calculate an area under the receiver operating curve (AUOC)
Medical University of South Carolina
Other
Voice Analysis in Patients Receiving Electroconvulsive Therapy
Acronym: VAPRE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04059952
Bipolar Depression, Bipolar Disorder
Boston, Massachusetts, United States
View Trial DetailsNCT04939649
Bipolar Depression, Bipolar Disorder
Dublin, Ireland
View Trial DetailsNCT06126198
Bipolar Depression, Bipolar Disorder
Uppsala, Sweden
View Trial DetailsNCT03711019
Behavior, Behavioral Symptoms
Vancouver, British Columbia, Canada
View Trial Details